Wird geladen...
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Although many patients are cured from prostate cancer (PCa) by surgery only, there are still patients who will experience rising prostate-specific antigen (PSA) levels after surgery, a condition known as biochemical recurrence (BCR). Novel protein prognostic markers in PCa tissue might enable findin...
Gespeichert in:
Veröffentlicht in: | Oncotarget |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Impact Journals LLC
2018
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6284859/ https://ncbi.nlm.nih.gov/pubmed/30559929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26342 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|